2023
Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016–2019
Sheth S, Johnson N, Sullivan E, Torres A, Oliveira C, Niccolai L. Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016–2019. Journal Of Women's Health 2023, 33: 28-32. PMID: 37943625, PMCID: PMC10794823, DOI: 10.1089/jwh.2022.0456.Peer-Reviewed Original ResearchConceptsMid-adult womenVaccination statusHPV vaccinationHPV vaccineHuman Papillomavirus Vaccination StatusHPV vaccination statusHuman papillomavirus vaccinationAge 26 yearsHealth care providersCross-sectional surveyPapillomavirus vaccinationUnvaccinated womenVaccinated womenVaccine informationCare providersVaccinationAdult womenVaccineWomenBehavioral correlatesCorrelatesStatusPotential benefitsYearsParticipantsA review of data systems for assessing the impact of HPV vaccination in selected high-income countries
Wang W, Kothari S, Khoury H, Niccolai L, Garland S, Sundström K, de Pouvourville G, Bonanni P, Chen Y, Franco E. A review of data systems for assessing the impact of HPV vaccination in selected high-income countries. Expert Review Of Vaccines 2023, 22: 161-179. PMID: 36576068, DOI: 10.1080/14760584.2023.2162505.Peer-Reviewed Original ResearchConceptsHigh-income countriesHPV vaccinationCervical cancer prevention policyCharacteristics of HPVHuman papillomavirus vaccinationCervical screening programmeEarly detection measuresCancer prevention policiesWorld Health OrganizationPapillomavirus vaccinationCervical cancerVaccination coverageDisease outcomeScreening programElimination effortsGlobal eliminationPrevention programsTreatment programData SystemVaccinationHealth OrganizationHPVTargeted reviewPrevention policiesUnited States
2022
Messaging of Different Disease Outcomes for Human Papillomavirus Vaccination: A Systematic Review
Niccolai L, Johnson N, Torres A, Sullivan E, Hansen C. Messaging of Different Disease Outcomes for Human Papillomavirus Vaccination: A Systematic Review. Journal Of Adolescent Health 2022, 72: 334-343. PMID: 36529616, DOI: 10.1016/j.jadohealth.2022.10.018.Peer-Reviewed Original ResearchConceptsHuman papillomavirus vaccinationDifferent health outcomesPapillomavirus vaccinationHealth outcomesSystematic reviewVaccination
2017
Cervical Adenocarcinoma in Situ in the United States: Results from Population-based Laboratory Surveillance, 2008–2014
Cleveland A, Johnson M, Gargano J, Park I, Griffin M, Niccolai L, Schafer S, Bennett N, Markowitz L, Unger E. Cervical Adenocarcinoma in Situ in the United States: Results from Population-based Laboratory Surveillance, 2008–2014. Open Forum Infectious Diseases 2017, 4: s68-s69. PMCID: PMC5632134, DOI: 10.1093/ofid/ofx162.164.Peer-Reviewed Original ResearchNon-vaccine typesHPV typesCervical cancer screening methodsHPV typing resultsL1 consensus PCRHuman papillomavirus vaccinationPopulation-based surveillanceCancer screening methodsChi-square testCIN3 casesPapillomavirus vaccinationHPV typingMedian ageHPV-18Primary preventionCervical adenocarcinomaVaccine preventionPrecursor lesionsAIS casesCIN3Positive specimensHR typesCIN2Disease controlCell precursors
2015
PHS112 Human Papillomavirus (HPV) Vaccination during well-Child visits in privately insured Males 9-21 years of age in the United States in 2012
Zhang D, Huang M, Kulkarni A, Niccolai L. PHS112 Human Papillomavirus (HPV) Vaccination during well-Child visits in privately insured Males 9-21 years of age in the United States in 2012. Value In Health 2015, 18: a266-a267. DOI: 10.1016/j.jval.2015.03.1551.Peer-Reviewed Original ResearchHuman papillomavirus vaccinationWell-child visitsYears of agePapillomavirus vaccinationMales 9VaccinationVisits